Welcome to our dedicated page for Littelfuse news (Ticker: $LFUS), a resource for investors and traders seeking the latest updates and insights on Littelfuse stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Littelfuse's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Littelfuse's position in the market.
Littelfuse, Inc. (NASDAQ: LFUS) reported Q1 net sales of $535 million, down 12% YoY, with GAAP diluted EPS at $1.93. The company expects Q2 net sales of $525-$555 million with adjusted diluted EPS at $1.65-$1.85. Littelfuse approved a $300 million stock repurchase program and a $0.65 cash dividend per share. The company remains confident in a return to growth in 2024.